Filing Details
- Accession Number:
- 0001104659-17-000315
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-03 18:35:40
- Reporting Period:
- 2017-01-01
- Filing Date:
- 2017-01-03
- Accepted Time:
- 2017-01-03 18:35:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1491576 | Tesaro Inc. | TSRO | Pharmaceutical Preparations (2834) | 272249687 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1653276 | Jr. H. Martin Huber | C/O Tesaro, Inc. 1000 Winter Street, Suite 3300 Waltham MA 02451 | Svp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-01-01 | 500 | $0.00 | 0 | No | 4 | A | Direct | |
Common Stock | Disposition | 2017-01-03 | 190 | $136.26 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the vesting of restricted stock units following satisfaction of certain performance criteria. Each restricted stock unit represents the right to receive one share of common stock.
- This sale was effected in accordance with the terms of the underlying restricted stock unit award agreement and was made in order to pay the tax liability arising from the vesting of restricted stock units.